| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 7 | -268,485 | 100% | $94.42 | -$25,351,182 |
| Net | -7 | -268,485 | -100% | -$25,351,182 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Noel R. Wallace | Chairman, President & CEO, Director | $44,176,102 | -$4,279,496 | -8.8% | 23 Feb 2026 |
| Jennifer Daniels | CLO and Secretary | $8,879,501 | -$2,075,399 | -19% | 23 Feb 2026 |
| Shane Grant | COO, Americas | $8,126,234 | 11 Sep 2025 | ||
| Philip G. Shotts | Vice President and Controller | $7,801,035 | 16 May 2022 | ||
| Panagiotis Tsourapas | COO, Eur., APac, Afr Eur, Skin | $7,760,816 | -$4,778,437 | -38% | 23 Feb 2026 |
| Stanley J. Sutula III | Chief Financial Officer | $7,244,263 | -$9,223,288 | -56% | 23 Feb 2026 |
| John T. Cahill | Director | $5,680,675 | 12 May 2025 | ||
| Prabha Parameswaran | Vice Chair | $5,473,308 | 12 Sep 2025 | ||
| Patricia Verduin | SVP, Global Technology | $5,299,431 | 07 Nov 2022 | ||
| John P. Bilbrey | Director | $3,298,653 | 02 Jan 2026 | ||
| Lorrie M. Norrington | Director | $3,118,711 | 02 Jan 2026 | ||
| Sally Massey | Chief Human Resources Officer | $2,860,731 | -$1,806,531 | -39% | 23 Feb 2026 |
| Stephen I. Sadove | Director | $2,843,954 | 15 May 2023 | ||
| John Hazlin | Chief Growth Officer | $2,833,323 | -$1,978,211 | -41% | 23 Feb 2026 |
| Gregory Malcolm | EVP and Controller | $2,268,475 | -$1,209,822 | -35% | 23 Feb 2026 |
| C. Martin Harris | Director | $2,093,131 | 12 May 2025 | ||
| Michael B. Polk | Director | $2,017,279 | 15 May 2023 | ||
| John W. Kooyman | Chief of Staff | $1,674,129 | 12 Sep 2024 | ||
| Lisa Edwards | Director | $1,473,022 | 12 May 2025 | ||
| Martina Hundmejean | Director | $1,273,633 | 12 May 2025 | ||
| Kimberly A. Nelson | Director | $1,096,918 | 12 May 2025 | ||
| Steven A. Cahillane | Director | $620,017 | 12 May 2025 | ||
| Brian Newman | Director | $420,764 | 02 Jan 2026 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| John Hazlin | CL | Common Stock | Tax liability | -20% | -6,117 | 24,422 | 23 Feb 2026 | Direct | ||
| John Hazlin | CL | Common Stock | Award | 72.2% | 12,803 | 30,539 | 23 Feb 2026 | Direct | ||
| Jennifer Daniels | CL | Common Stock | Tax liability | -12.1% | -12,351 | 89,844 | 23 Feb 2026 | Direct | ||
| Jennifer Daniels | CL | Common Stock | Award | 33.7% | 25,742 | 102,195 | 23 Feb 2026 | Direct | ||
| Gregory Malcolm | CL | Common Stock | Tax liability | -12.4% | -2,260 | 15,898 | 23 Feb 2026 | Direct | ||
| Gregory Malcolm | CL | Common Stock | Award | 52.7% | 6,268 | 18,158 | 23 Feb 2026 | Direct | ||
| Sally Massey | CL | Common Stock | Tax liability | -26.8% | -8,206 | 22,384 | 23 Feb 2026 | Direct | ||
| Sally Massey | CL | Common Stock | Award | 121.9% | 16,805 | 30,590 | 23 Feb 2026 | Direct | ||
| Stanley J. Sutula III | CL | Common Stock | Tax liability | -21% | -19,746 | 74,320 | 23 Feb 2026 | Direct | ||
| Stanley J. Sutula III | CL | Common Stock | Award | 69.8% | 38,678 | 94,066 | 23 Feb 2026 | Direct | ||
| Panagiotis Tsourapas | CL | Common Stock | Tax liability | -37.7% | -13,081 | 21,629 | 23 Feb 2026 | Direct | ||
| Panagiotis Tsourapas | CL | Common Stock | Award | 287% | 25,742 | 34,710 | 23 Feb 2026 | Direct | ||
| Noel R. Wallace | CL | Common Stock | Tax liability | -15.9% | -68,252 | 361,921 | 23 Feb 2026 | Direct | ||
| Noel R. Wallace | CL | Common Stock | Award | 46.6% | 136,710 | 430,173 | 23 Feb 2026 | Direct | ||
| Panagiotis Tsourapas | CL | Common Stock | Sale | -59% | $1,467,111 | $97.81 | -15,000 | 10,415 | 12 Feb 2026 | Direct |
| Panagiotis Tsourapas | CL | Common Stock | Options Exercise | 144% | 15,000 | 25,415 | 12 Feb 2026 | Direct | ||
| Panagiotis Tsourapas | CL | Stock Option (Right to Buy) | Options Exercise | -42.9% | -15,000 | 19,938 | 12 Feb 2026 | Direct | ||
| Panagiotis Tsourapas | CL | Common Stock | Sale | -77.1% | $3,311,326 | $94.61 | -35,000 | 10,415 | 11 Feb 2026 | Direct |
| Panagiotis Tsourapas | CL | Common Stock | Options Exercise | 336% | 35,000 | 45,415 | 11 Feb 2026 | Direct | ||
| Panagiotis Tsourapas | CL | Stock Option (Right to Buy) | Options Exercise | -50% | -35,000 | 34,938 | 11 Feb 2026 | Direct | ||
| John Hazlin | CL | Common Stock | Sale | -54.3% | $1,978,211 | $94.25 | -20,989 | 17,645 | 10 Feb 2026 | Direct |
| John Hazlin | CL | Common Stock | Options Exercise | 119% | 20,989 | 38,634 | 10 Feb 2026 | Direct | ||
| John Hazlin | CL | Stock Option (Right to Buy) | Options Exercise | -100% | -20,989 | 0 | 10 Feb 2026 | Direct | ||
| Gregory Malcolm | CL | Common Stock | Sale | -51.8% | $1,209,822 | $94.91 | -12,747 | 11,879 | 06 Feb 2026 | Direct |
| Gregory Malcolm | CL | Common Stock | Options Exercise | 107.3% | 12,747 | 24,626 | 06 Feb 2026 | Direct | ||
| Gregory Malcolm | CL | Stock Option (Right to Buy) | Options Exercise | -100% | -12,747 | 0 | 06 Feb 2026 | Direct | ||
| Sally Massey | CL | Common Stock | Sale | -53.6% | $1,506,287 | $95.03 | -15,851 | 13,751 | 05 Feb 2026 | Direct |
| Sally Massey | CL | Common Stock | Options Exercise | 115.3% | 15,851 | 29,602 | 05 Feb 2026 | Direct | ||
| Sally Massey | CL | Stock Option (Right to Buy) | Options Exercise | -100% | -15,851 | 0 | 05 Feb 2026 | Direct | ||
| Stanley J. Sutula III | CL | Common Stock | Sale | -63.9% | $9,223,288 | $94.27 | -97,843 | 55,310 | 04 Feb 2026 | Direct |
| Stanley J. Sutula III | CL | Common Stock | Options Exercise | 176.9% | 97,843 | 153,153 | 04 Feb 2026 | Direct | ||
| Stanley J. Sutula III | CL | Stock Option (Right to Buy) | Options Exercise | -100% | -97,843 | 0 | 04 Feb 2026 | Direct | ||
| Jennifer Daniels | CL | Common Stock | Sale | -22.4% | $2,075,399 | $94.34 | -22,000 | 76,406 | 04 Feb 2026 | Direct |
| Jennifer Daniels | CL | Common Stock | Options Exercise | 28.8% | 22,000 | 98,406 | 04 Feb 2026 | Direct | ||
| Jennifer Daniels | CL | Stock Option (Right to Buy) | Options Exercise | -100% | -22,000 | 0 | 04 Feb 2026 | Direct | ||
| Noel R. Wallace | CL | Common Stock | Sale | -13.4% | $4,279,496 | $93.91 | -45,568 | 293,188 | 04 Feb 2026 | Direct |
| Brian Newman | CL | Common Stock | Award | 4.69% | 238 | 5,313 | 02 Jan 2026 | Direct | ||
| Lorrie M. Norrington | CL | Common Stock | Award | 0.85% | 333 | 39,648 | 02 Jan 2026 | Direct | ||
| John P. Bilbrey | CL | Common Stock | Award | 0.82% | 301 | 37,195 | 02 Jan 2026 | Direct | ||
| Noel R. Wallace | CL | Common Stock | Tax liability | -0.38% | -1,307 | 338,756 | 03 Dec 2025 | Direct | ||
| Panagiotis Tsourapas | CL | Common Stock | Tax liability | -2.08% | -221 | 10,415 | 03 Dec 2025 | Direct | ||
| Stanley J. Sutula III | CL | Common Stock | Tax liability | -0.69% | -385 | 55,310 | 03 Dec 2025 | Direct | ||
| Gregory Malcolm | CL | Common Stock | Tax liability | -0.34% | -41 | 11,879 | 03 Dec 2025 | Direct | ||
| John Hazlin | CL | Common Stock | Tax liability | -0.88% | -156 | 17,645 | 03 Dec 2025 | Direct | ||
| Jennifer Daniels | CL | Common Stock | Tax liability | -0.28% | -213 | 76,406 | 03 Dec 2025 | Direct | ||
| Sally Massey | CL | Common Stock | Sale | -8.25% | $100,061 | $80.89 | -1,237 | 13,751 | 21 Nov 2025 | Direct |
| Brian Newman | CL | Common Stock | Award | 4.71% | 228 | 5,065 | 01 Oct 2025 | Direct | ||
| Lorrie M. Norrington | CL | Common Stock | Award | 0.82% | 319 | 39,061 | 01 Oct 2025 | Direct | ||
| John P. Bilbrey | CL | Common Stock | Award | 0.79% | 289 | 36,658 | 01 Oct 2025 | Direct | ||
| Jennifer Daniels | CL | Common Stock | Tax liability | -1.16% | -900 | 76,559 | 13 Sep 2025 | Direct |